02934oam 2200637zu 450 99621312850331620210807001422.00-19-159556-X0-19-959124-5(CKB)2670000000065777(SSID)ssj0000466535(PQKBManifestationID)11269584(PQKBTitleCode)TC0000466535(PQKBWorkID)10466083(PQKB)11216770(StDuBDS)EDZ0000076926(EXLCZ)99267000000006577720160829d2011 uy engur|||||||||||txtccrVirgil's Schoolboys: The Poetics of Pedagogy in Renaissance EnglandOxford Oxford University Press20111 online resourceClassical presences Virgil's schoolboys Bibliographic Level Mode of Issuance: MonographPrint version 9780199591244 Includes bibliographical references and index.Introduction. Virgil's schooldays ; Master, scholar, schoolbook -- The poet as schoolbook. 'I must read Virgil' ; 'Amo magistrum, I love the maister' ; The place of commentary and the works of Amor -- Pastoral and the painful schoolmaster. Echo, eclogue, dialogue ; 'The schoolemaister of Bacchus' ; 'Now thou art gone, now thou art gone' -- Placement and pedagogy in the Georgics. 'The rurall part of Virgil' ; Virgil's schoolroom ; 'Some boks have resistit, standeth stil' ; Print and pedagogy -- Forgetting epic. After Troy ; Virgil's wild goose ; Epic struggles ; 'A palmer with a rodde' -- Conclusion : 'Virgilius poëtarum doctissimus'.Examining the ways in which Virgil's poems were received and employed in the schoolrooms of 16th- and 17th-century England Andrew Wallace argues that the Roman poet is an original theorist of the nature and mechanics of instruction.Classical presences.Virgil's schoolboys: the poetics of pedagogy in Renaissance EnglandClassical presencesEducationHistory16th centuryEnglandEducationHistory17th centuryEnglandEducationHILCCLanguages & LiteraturesHILCCSocial SciencesHILCCGreek & Latin Languages & LiteraturesHILCCHistory of EducationHILCCEducationHistoryEducationHistoryEducationLanguages & LiteraturesSocial SciencesGreek & Latin Languages & LiteraturesHistory of Education873.01Wallace Andrew51156PQKBBOOK996213128503316Virgil's Schoolboys: The Poetics of Pedagogy in Renaissance England2367084UNISA04379nam 2200985z- 450 991057687970332120220621(CKB)5720000000008378(oapen)https://directory.doabooks.org/handle/20.500.12854/84513(oapen)doab84513(EXLCZ)99572000000000837820202206d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierPresent and Future of Personalised Medicine for Endocrine CancersBaselMDPI - Multidisciplinary Digital Publishing Institute20221 online resource (140 p.)3-0365-4330-9 3-0365-4329-5 Major technological advances in genomics have made it possible to identify critical genetic alterations in cancer, rendering oncology well along the path to "personalised cancer medicine". Thanks to developments in genetics, several mutations and gene rearrangements have been identified in patients with endocrine cancers (e.g., thyroid and adrenocortical carcinoma). In particular, each patient can be considered as a unique, individual one, with unique genetic information. The aim of this Special Issue is to offer an overview of exciting new research in the area of endocrine tumours may set the stage for an innovative personalised management and precision medicine modalities for individualised care.New affordable individual genomic analyses, as well as the opportunity to test new compounds in primary cells may allow a personalised management of patients with endocrine malignancies. This approach may improve the prediction of clinical outcome and therapeutic effectiveness, as well as help to avoid the use of ineffective drugs. However, further efforts are needed to obtain an adjustment of clinical management in patients with endocrine cancers that would rely solely or in great part on genetic information. This Special Issue includes basic, translational, and clinical papers on personalised medicine in endocrine malignancies (i.e., thyroid and adrenal), especially focusing on diagnostic and prognostic biomarkers, as well as novel drug targets or targeted treatments, including eventual clinical trials.Medicine and Nursingbicsscadjuvant treatmentadrenal adenomasadrenal cortexadrenal tumorsadrenocortical canceraggressive PitNETaggressive pituitary adenomaaggressive pituitary tumorangiogenesisBRAFBRAF V600EcarcinomaCushing's diseasedifferentiated thyroid cancerfocus group interviewgene expressionhyaluronan synthase 1immune checkpoint inhibitors (ICIs)information needs and preferencesintratumoral heterogeneityipilimumabki-67lenvatinibmitotanemolecular clustersmultikinase inhibitorsn/aneuroendocrine tumoursnivolumabosteopontinp27p53papillary thyroid cancerparagangliomapersonalized medicinephaeochromocytomapituitary carcinomapredictive markerpredictorsprolactinomaradioiodine resistanceRAS mutationrecurrencerecurrence free survivalresponse to treatmentRET/PTC rearrangementsreticulinsorafenibsurvivalSUV PET/CTthyroid tumortimingMedicine and NursingRonchi Cristina Ledt1326491Altieri BarbaraedtRonchi Cristina LothAltieri BarbaraothBOOK9910576879703321Present and Future of Personalised Medicine for Endocrine Cancers3037560UNINA